[{"Assets_0_Q2_USD":1126724000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":133503262.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":134826805.0,"StockholdersEquity_0_Q2_USD":1023812000.0,"RevenuesConverted_2_Q2_USD":38389000.0,"RevenuesConverted_1_Q2_USD":44000.0,"NetIncomeLossConverted_2_Q2_USD":-103951000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":134826805.0,"NetIncomeLossConverted_1_Q2_USD":-70936000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.78,"EarningsPerShareDiluted_1_Q2_USD":-0.53,"EarningsPerShareBasic_2_Q2_USD":-0.78,"EarningsPerShareBasic_1_Q2_USD":-0.53,"CommonStockSharesOutstanding_0_Q2_shares":142120731.0,"CommonStockSharesConverted_0_Q2_shares":142120731.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-90498000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":133503262.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]